Squarepoint Ops LLC Corvus Pharmaceuticals, Inc. Transaction History
Squarepoint Ops LLC
- $99.2 Billion
- Q4 2024
A detailed history of Squarepoint Ops LLC transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 98,144 shares of CRVS stock, worth $423,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
98,144
Previous 12,080
712.45%
Holding current value
$423,000
Previous $63,000
709.52%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CRVS
# of Institutions
102Shares Held
38.1MCall Options Held
2.75MPut Options Held
1.17M-
Orbimed Advisors LLC San Diego, CA6.94MShares$29.9 Million0.98% of portfolio
-
Samlyn Capital, LLC New York, NY6.67MShares$28.7 Million0.56% of portfolio
-
Adams Street Partners LLC Chicago, IL3.28MShares$14.1 Million18.22% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.03MShares$13.1 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY2.68MShares$11.5 Million0.23% of portfolio
About Corvus Pharmaceuticals, Inc.
- Ticker CRVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,553,500
- Market Cap $201M
- Description
- Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...